Axitinib dose titration: what's the limiting factor?

Lancet Oncol. 2013 Nov;14(12):1152-4. doi: 10.1016/S1470-2045(13)70489-3. Epub 2013 Oct 18.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Axitinib
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / secondary*
  • Female
  • Humans
  • Imidazoles / administration & dosage*
  • Indazoles / administration & dosage*
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / pathology*
  • Male
  • Protein Kinase Inhibitors / administration & dosage*

Substances

  • Antineoplastic Agents
  • Imidazoles
  • Indazoles
  • Protein Kinase Inhibitors
  • Axitinib